Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oleogel-S10 in Grade 2a Burn Wounds
NCT01657292Phase 3Completed
- Sponsor
- Birken AG
- Start
- Aug 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of birch triterpenes in burn injury, sponsored by Birken AG. Started Aug 2012; status: completed.
02
Drugs
birch triterpenes
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT01657292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01657292.